Maritza Quiroz-Reyna
Research Subjects
Research Interests
Maritza Quiroz-Reyna has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Giancarlo Quiroz-Chunga
Roe Laboratory, Lima 15076, Peru
3 shared publications - Luis Alvarado
Laboratorios Roe, lima, Peru
3 shared publications - William Castillo-Aguilar
Roe Laboratory, Lima 15076, Peru
3 shared publications - Flor Belinda Quedo-Salazar
Laboratorios Roe, Lima Perú
2 shared publications - Juan Carlos Gómez de la Torre
Facultad de Medicina Humana, Universidad de Piura
1 shared publication - Luis Manuel Ramos-Yesquen
Laboratorios Roe, Lima Perú
1 shared publication
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3870
Analytical Inclusivity of Three Commercial Real-Time PCR Platforms Against Carbapenemase Allelic Variants in Peruvian Clinical Isolates
Objectives: Rapid molecular detection of carbapenemase-producing Gram-negative bacilli is crucial for targeted antimicrobial therapy, but regional gene sequence diversity can impair commercial PCR assays. This study evaluated the analytical inclusivity of three commercial real-time PCR platforms (Xpert Carba-R on the GeneXpert system, Galaxy Lite, and Molecular Mouse) against carbapenemase alleles circulating in Peru, including the regionally relevant blaIMP-74 and blaIMP-93 alleles. Methods: We analyzed a positive-enriched challenge panel of 23 non-duplicate clinical isolates previously characterized by whole-genome sequencing (WGS): 10 Enterobacterales and 13 Pseudomonas aeruginosa carrying 26 carbapenemase genes across 12 variants (blaKPC-2/35, blaNDM-1/5, blaOXA-48/181/232, blaVIM-2, and blaIMP-16/18/74/93); inclusivity was calculated per WGS-confirmed target gene, and Molecular Mouse was evaluated on a 16-target subset including at least one representative of each allele. Results: Galaxy Lite detected all carbapenemase alleles evaluated (12/12 alleles; gene-level analytical inclusivity 100%, 26/26 target genes, 95% CI: 86.8–100%). Xpert Carba-R and Molecular Mouse each detected 8 of the 12 alleles (100% of KPC, NDM, OXA-48-like, and VIM alleles), failing to detect any of the four IMP alleles evaluated. Overall gene-level inclusivity was 53.8% (14/26 target genes, 95% CI: 33.4–73.4%) for Xpert Carba-R and 62.5% (10/16 target genes, 95% CI: 35.4–84.8%) for Molecular Mouse. Conclusions: In this small, positive-enriched panel, two of the three commercial PCR panels did not detect the IMP alleles tested, a finding that may be related to primer/probe–target sequence divergence, although this mechanism was not investigated. These results support the local verification of commercial carbapenemase PCR assays against circulating alleles before routine implementation.
- 19 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3870
Open AccessAnalytical Inclusivity of Three Commercial Real-Time PCR Platforms Against Carbapenemase Allelic Variants in Peruvian Clinical Isolates
Objectives: Rapid molecular detection of carbapenemase-producing Gram-negative bacilli is crucial for targeted antimicrobial therapy, but regional gene sequence diversity can impair commercial PCR assays. This study evaluated the analytical inclusivity of three commercial real-time PCR platforms (Xpert Carba-R on the GeneXpert system, Galaxy Lite, and Molecular Mouse) against carbapenemase alleles circulating in Peru, including the regionally relevant blaIMP-74 and blaIMP-93 alleles. Methods: We analyzed a positive-enriched challenge panel of 23 non-duplicate clinical isolates previously characterized by whole-genome sequencing (WGS): 10 Enterobacterales and 13 Pseudomonas aeruginosa carrying 26 carbapenemase genes across 12 variants (blaKPC-2/35, blaNDM-1/5, blaOXA-48/181/232, blaVIM-2, and blaIMP-16/18/74/93); inclusivity was calculated per WGS-confirmed target gene, and Molecular Mouse was evaluated on a 16-target subset including at least one representative of each allele. Results: Galaxy Lite detected all carbapenemase alleles evaluated (12/12 alleles; gene-level analytical inclusivity 100%, 26/26 target genes, 95% CI: 86.8–100%). Xpert Carba-R and Molecular Mouse each detected 8 of the 12 alleles (100% of KPC, NDM, OXA-48-like, and VIM alleles), failing to detect any of the four IMP alleles evaluated. Overall gene-level inclusivity was 53.8% (14/26 target genes, 95% CI: 33.4–73.4%) for Xpert Carba-R and 62.5% (10/16 target genes, 95% CI: 35.4–84.8%) for Molecular Mouse. Conclusions: In this small, positive-enriched panel, two of the three commercial PCR panels did not detect the IMP alleles tested, a finding that may be related to primer/probe–target sequence divergence, although this mechanism was not investigated. These results support the local verification of commercial carbapenemase PCR assays against circulating alleles before routine implementation.
- Open Access
- 15 May 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 11 (1) , 53-56
Identification of Trichophyton benhamiae by MALDI-TOF Mass Spectrometry. First report in Peru
Is an emerging zoophilic dermatophyte that mainly infects skin and scalp and has been reported in Asia, America and Europe. It has two phenotypic variants: one with white colonies and the other with yellow colonies. Morphological identification of is not sufficient and can be confused with or . Genomic or proteomic analysis is required to establish a definitive identification. We present three dermatophyte strains obtained from the skin, nails and scalp of human infections in which macroscopic and microscopic examinations were not sufficient to identify the species. The final identification of was performed using MALDI-TOF mass spectrometry. This is the first report of in Peru.
- 15 May 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 11 (1) , 53-56
Open AccessIdentification of Trichophyton benhamiae by MALDI-TOF Mass Spectrometry. First report in Peru
Is an emerging zoophilic dermatophyte that mainly infects skin and scalp and has been reported in Asia, America and Europe. It has two phenotypic variants: one with white colonies and the other with yellow colonies. Morphological identification of is not sufficient and can be confused with or . Genomic or proteomic analysis is required to establish a definitive identification. We present three dermatophyte strains obtained from the skin, nails and scalp of human infections in which macroscopic and microscopic examinations were not sufficient to identify the species. The final identification of was performed using MALDI-TOF mass spectrometry. This is the first report of in Peru.
- Open Access
- 10 December 2023
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 27 (4) , 193-202
Identificación y sensibilidad antibiótica de bacilos Gram negativos directamente del hemocultivo positivo
Objetivo: El objetivo fue determinar la concordancia de la identificación y sensibilidad antibiótica directa del hemocultivo positivo para bacilos Gram negativos, con el sistema Vitek 2 frente al procedimiento estándar.Materiales y métodos: Para el procedimiento directo se extrajeron 8 ml de la botella de hemocultivo positivo, se inocularon en un tubo de extracción de sangre con gel separador, se centrifugó por 10 minutos a 1000g, se resuspendió el pellet con 0.5 ml de solución salina estéril y se preparó el inóculo de las tarjetas deidentificación y sensibilidad antibiótica. La concordancia de identificación se evaluó con el índice Kappa, la sensibilidad antibiótica con essential agreement (EA) y categorical agreement (CA).Resultados: El acierto de identificación (%) y el índice kappa(k) para las cinco especies más frecuentes fue : E. coli 98.0% (48/49) k=0.99, K. pneumoniae 100% (33/33) k=1.0, complejo E. cloacae 100% (13/13) k=1.0, A. baumannii 95% (19/20) k=0.97, P. aeruginosa 66.7% (8/12) k=0.79. Los valores essential agreement y, categorical agreementt para 2175 combinaciones bacteria-antibiótico fueron 97.5% y 97.1% respectivamente.Conclusión: El procedimiento directo del hemocultivo positivo muestra buena concordancia para las principales especies de bacilos Gram negativos y permite obtener resultados 16 a 24 horas antes que el procedimiento estándar.
- 10 December 2023
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 27 (4) , 193-202
Open AccessIdentificación y sensibilidad antibiótica de bacilos Gram negativos directamente del hemocultivo positivo
Objetivo: El objetivo fue determinar la concordancia de la identificación y sensibilidad antibiótica directa del hemocultivo positivo para bacilos Gram negativos, con el sistema Vitek 2 frente al procedimiento estándar.Materiales y métodos: Para el procedimiento directo se extrajeron 8 ml de la botella de hemocultivo positivo, se inocularon en un tubo de extracción de sangre con gel separador, se centrifugó por 10 minutos a 1000g, se resuspendió el pellet con 0.5 ml de solución salina estéril y se preparó el inóculo de las tarjetas deidentificación y sensibilidad antibiótica. La concordancia de identificación se evaluó con el índice Kappa, la sensibilidad antibiótica con essential agreement (EA) y categorical agreement (CA).Resultados: El acierto de identificación (%) y el índice kappa(k) para las cinco especies más frecuentes fue : E. coli 98.0% (48/49) k=0.99, K. pneumoniae 100% (33/33) k=1.0, complejo E. cloacae 100% (13/13) k=1.0, A. baumannii 95% (19/20) k=0.97, P. aeruginosa 66.7% (8/12) k=0.79. Los valores essential agreement y, categorical agreementt para 2175 combinaciones bacteria-antibiótico fueron 97.5% y 97.1% respectivamente.Conclusión: El procedimiento directo del hemocultivo positivo muestra buena concordancia para las principales especies de bacilos Gram negativos y permite obtener resultados 16 a 24 horas antes que el procedimiento estándar.